The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant

Abbott Laboratories has agreed to acquire St. Jude Medical for $25bn, creating a third player, along with Boston Scientific and Medtronic, that competes in all major sectors of the cardiovascular device business.